Literature DB >> 21243314

Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.

G A DosReis1.   

Abstract

Infection with the protozoan parasite Trypanosoma cruzi leads to Chagas disease, which affects millions of people in Latin America. Infection with T. cruzi cannot be eliminated by the immune system. A better understanding of immune evasion mechanisms is required in order to develop more effective vaccines. During the acute phase, parasites replicate extensively and release immunomodulatory molecules that delay parasite-specific responses mediated by T cells. This immune evasion allows the parasite to spread in the host. In the chronic phase, parasite evasion relies on its replication strategy of hijacking the TGF-β signaling pathway involved in inflammation and tissue regeneration. In this article, the mechanisms of immune evasion described for T. cruzi are reviewed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21243314     DOI: 10.1590/s0100-879x2011007500005

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  19 in total

Review 1.  Advances and challenges towards a vaccine against Chagas disease.

Authors:  Israel Quijano-Hernandez; Eric Dumonteil
Journal:  Hum Vaccin       Date:  2011-11-01

2.  Role of the PD-1/PD-L1 Pathway in Experimental Trypanosoma cruzi Infection and Potential Therapeutic Options.

Authors:  Yanina Arana; Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

3.  Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.

Authors:  Christian Emerson Rosas-Jorquera; Luiz Roberto Sardinha; Fernando Delgado Pretel; André Luis Bombeiro; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

4.  Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.

Authors:  José Ronnie Vasconcelos; Oscar Bruña-Romero; Adriano F Araújo; Mariana R Dominguez; Jonatan Ersching; Bruna C G de Alencar; Alexandre V Machado; Ricardo T Gazzinelli; Karina R Bortoluci; Gustavo P Amarante-Mendes; Marcela F Lopes; Mauricio M Rodrigues
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

5.  IL-10-IFN-γ double producers CD4+ T cells are induced by immunization with an amastigote stage specific derived recombinant protein of Trypanosoma cruzi.

Authors:  Yevel Flores-García; José Luis Rosales-Encina; Abhay R Satoskar; Patricia Talamás-Rohana
Journal:  Int J Biol Sci       Date:  2011-09-08       Impact factor: 6.580

6.  MIF synergizes with Trypanosoma cruzi antigens to promote efficient dendritic cell maturation and IL-12 production via p38 MAPK.

Authors:  Cesar A Terrazas; Erik Huitron; Alicia Vazquez; Imelda Juarez; Griselda M Camacho; Elsa A Calleja; Miriam Rodriguez-Sosa
Journal:  Int J Biol Sci       Date:  2011-10-25       Impact factor: 6.580

7.  IFN-γ plays a unique role in protection against low virulent Trypanosoma cruzi strain.

Authors:  Adele A Rodrigues; Jasson S S Saosa; Grace K da Silva; Flávia A Martins; Aline A da Silva; Cecílio P da Silva Souza Neto; Catarina V Horta; Dario S Zamboni; João S da Silva; Eloisa A V Ferro; Claudio V da Silva
Journal:  PLoS Negl Trop Dis       Date:  2012-04-03

Review 8.  The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host.

Authors:  Alexandre Morrot
Journal:  Scientifica (Cairo)       Date:  2013-12-22

Review 9.  Immune Evasion Strategies of Trypanosoma cruzi.

Authors:  Ana Flávia Nardy; Célio Geraldo Freire-de-Lima; Alexandre Morrot
Journal:  J Immunol Res       Date:  2015-07-09       Impact factor: 4.818

Review 10.  Impairment of T cell function in parasitic infections.

Authors:  Vasco Rodrigues; Anabela Cordeiro-da-Silva; Mireille Laforge; Ali Ouaissi; Khadija Akharid; Ricardo Silvestre; Jérôme Estaquier
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.